Literature DB >> 3892155

Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon.

P M Grimley, G L Davis, Y H Kang, J S Dooley, J Strohmaier, J H Hoofnagle.   

Abstract

Tubuloreticular inclusions (TRI) developed within the endoplasmic reticulum of peripheral blood mononuclear cells (PBMC) sampled from eight patients with chronic type B hepatitis during cycles of therapy with DNA-recombinant human alpha-interferon (rIFN alpha A). Each cycle of therapy consisted of a series of six intramuscular injections (triweekly) of a fixed dose of rIFN alpha A (from 18 to 68 X 10(6) IU/dose). In PBMC examined by transmission electron microscopy, TRI were absent prior to therapy and developed during therapy in all cases. Peak serum levels of alpha-interferon (320 to 960 IU/ml) were achieved within 12 hours. At 24 hours. TRI were detected in 0.5 to 6.5% of PBMC sections, and they persisted in 1.4 to 6.8% of sections examined at 48 hours. After five sequential interferon doses, TRI were observed in 1.6 to 9.8% of PBMC sections. TRI could no longer be detected at 5 to 16 days after cessation of rIFN alpha A, but they reappeared during subsequent cycles of therapy. Subpopulations of the PBMC with TRI were differentiated by immunoelectron microscopy utilizing a battery of anti-Leu monoclonal antibodies: surface markers of T cells, helper/inducer or cytotoxic/suppressor T cell subsets, natural killer cells, or B-cells were identified by direct or indirect procedures utilizing avidin and biotinylated peroxidase. In cases analyzed with multiple monoclonal antisera, TRI were expressed in all of the major PBMC subpopulations. Monocytes with TRI were demonstrated by the endogenous peroxidase reaction. TRI were not found in circulating polymorphonuclear granulocytes. Lymphocytes isolated from healthy donors and exposed to rIFN alpha A (100 IU/ml), for 48 to 72 hours in vitro, developed TRI in proportions of PBMC sections (2.3 to 8.4%) comparable to those observed in the interferon-treated patients. Stimulation of lymphocytes with concanavalin A, for 72 hours before rIFN alpha A exposure, enhanced formation of TRI which could then be found in T blasts. Stimulation of donor lymphocytes with Sendai virus, a potent inducer of alpha-interferon, also resulted in formation of TRI by 48 hours. This suggested that lymphocytotrophic virus infections could exercise a primary role in the natural pathogenesis of TRI.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3892155

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Tubuloreticular structures in microglial cells, pericytes and endothelial cells in Alzheimer's disease.

Authors:  J Wegiel; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Human recombinant leukocyte interferon-alpha induces intracytoplasmic tubuloreticular structures and crystalline bodies in Kaposi's sarcoma cells in vivo.

Authors:  K H Marquart; R Engst; G Oehlschlaegel
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Cytomembranous inclusions in the peripheral nerves in AIDS.

Authors:  G N Fuller; J M Jacobs
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Tubuloreticular structures (TRS) and cylindric confronting cisternae (CCC) in childhood dermatomyositis.

Authors:  A Fidziańska; H H Goebel
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Membranous changes in primary malignant CNS lymphomas.

Authors:  F Slowik; K Jellinger
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Lupus-like glomerulonephritis: an autoimmune complication of hepatitis C infection.

Authors:  Liliane Hobeika; Monica Srivastava; Mai Vo; Marie D Philipneri; David S Brink; Nadia Wasi; Krista L Lentine
Journal:  CEN Case Rep       Date:  2012-03-27

Review 7.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 8.  A novel pathogenetic concept-antiviral immunity in lupus nephritis.

Authors:  Adriana Migliorini; Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2012-01-17       Impact factor: 28.314

9.  Fifty cases of human immunodeficiency virus (HIV) infection: immunoultrastructural study of circulating lymphocytes.

Authors:  W W Feremans; K Huygen; R Menu; C M Farber; J P de Caluwe; J P van Vooren; L Marcelis; L Andre; M Brasseur; H Bondue
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

Review 10.  Dermatomyositis and type 1 interferons.

Authors:  Steven A Greenberg
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.